Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

B lymphocytes in nonorgan-specific autoimmune diseases: implications for therapy.

Youinou P, Pers JO.

Lupus. 2012 Nov;21(13):1375-7. doi: 10.1177/0961203312460901. Epub 2012 Sep 12. No abstract available.

PMID:
22976931
[PubMed - indexed for MEDLINE]
2.

BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.

Sun J, Lin Z, Feng J, Li Y, Shen B.

Eur J Pharmacol. 2008 Nov 12;597(1-3):1-5. doi: 10.1016/j.ejphar.2008.08.027. Epub 2008 Aug 30. Review.

PMID:
18793632
[PubMed - indexed for MEDLINE]
3.

The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseases.

Mariette X.

Joint Bone Spine. 2004 Sep;71(5):357-60. Review. No abstract available.

PMID:
15474382
[PubMed - indexed for MEDLINE]
4.

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.

Mackay F, Silveira PA, Brink R.

Curr Opin Immunol. 2007 Jun;19(3):327-36. Epub 2007 Apr 12. Review.

PMID:
17433868
[PubMed - indexed for MEDLINE]
5.

Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.

Begum-Haque S, Sharma A, Christy M, Lentini T, Ochoa-Reparaz J, Fayed IF, Mielcarz D, Haque A, Kasper LH.

J Neuroimmunol. 2010 Feb 26;219(1-2):47-53. doi: 10.1016/j.jneuroim.2009.11.016. Epub 2010 Jan 19.

PMID:
20034680
[PubMed - indexed for MEDLINE]
6.

BAFF, APRIL, TWE-PRIL: who's who?

Daridon C, Youinou P, Pers JO.

Autoimmun Rev. 2008 Feb;7(4):267-71. doi: 10.1016/j.autrev.2007.05.002. Epub 2007 Jun 21. Review.

PMID:
18295728
[PubMed - indexed for MEDLINE]
7.

BAFF: B cell survival factor and emerging therapeutic target for autoimmune disorders.

Kalled SL, Ambrose C, Hsu YM.

Expert Opin Ther Targets. 2003 Feb;7(1):115-23.

PMID:
12556207
[PubMed - indexed for MEDLINE]
8.

B cell targeted therapies in autoimmune diseases.

Isenberg DA.

J Rheumatol Suppl. 2006 May;77:24-8. Review.

PMID:
16652442
[PubMed - indexed for MEDLINE]
9.

B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications.

Tuscano JM, Harris GS, Tedder TF.

Autoimmun Rev. 2003 Mar;2(2):101-8. Review.

PMID:
12848966
[PubMed - indexed for MEDLINE]
10.

[At the crossroads between B lymphoproliferative syndromes to autoimmune diseases are CD5-positive B-lymphocytes: a new hypothesis].

Youinou P.

Bull Acad Natl Med. 1999;183(1):159-69; discussion 170. Review. French.

PMID:
10371774
[PubMed - indexed for MEDLINE]
11.

Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs.

Xie P, Stunz LL, Larison KD, Yang B, Bishop GA.

Immunity. 2007 Aug;27(2):253-67.

PMID:
17723217
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.

Krumbholz M, Faber H, Steinmeyer F, Hoffmann LA, Kümpfel T, Pellkofer H, Derfuss T, Ionescu C, Starck M, Hafner C, Hohlfeld R, Meinl E.

Brain. 2008 Jun;131(Pt 6):1455-63. doi: 10.1093/brain/awn077. Epub 2008 May 12.

PMID:
18474519
[PubMed - indexed for MEDLINE]
Free Article
13.

[CD20 antibody for the treatment of systemic autoimmune diseases].

Tanaka Y.

Nihon Rinsho. 2005 May;63 Suppl 5:728-33. Review. Japanese. No abstract available.

PMID:
15954437
[PubMed - indexed for MEDLINE]
14.

B cell activator factor and a proliferation-inducing ligand at the cross-road of chronic lymphocytic leukemia and autoimmunity.

Ferrer G, Hodgson K, Montserrat E, Moreno C.

Leuk Lymphoma. 2009 Jul;50(7):1075-82. doi: 10.1080/10428190903013334.

PMID:
19557629
[PubMed - indexed for MEDLINE]
15.

B-cell: a logical target for treatment of rheumatoid arthritis.

Youinou P, Jamin C, Saraux A.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):318-28. Review.

PMID:
17543163
[PubMed - indexed for MEDLINE]
16.

[Rituximab and autoimmune disorders therapy].

Quint L.

Rev Med Interne. 2004 Oct;25(10):752-4. French.

PMID:
15471601
[PubMed - indexed for MEDLINE]
17.

Treating human autoimmune disease by depleting B cells.

Looney RJ.

Ann Rheum Dis. 2002 Oct;61(10):863-6. Review. No abstract available.

PMID:
12228152
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis.

Bataille R, Klein B.

Anticancer Res. 1988 Jul-Aug;8(4):707-10. Review.

PMID:
2460021
[PubMed - indexed for MEDLINE]
19.

B cell targeted therapy in autoimmunity.

Blank M, Shoenfeld Y.

J Autoimmun. 2007 Mar-May;28(2-3):62-8. Epub 2007 Mar 27. Review.

PMID:
17391915
[PubMed - indexed for MEDLINE]
20.

CD5: a safeguard against autoimmunity and a shield for cancer cells.

Dalloul A.

Autoimmun Rev. 2009 Feb;8(4):349-53. doi: 10.1016/j.autrev.2008.11.007. Epub 2008 Nov 27. Review.

PMID:
19041428
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk